Mette Lauritzen, PhD, joined Bruker BioSpin in 2020 as Market Product Manager for Nuclear Molecular Imaging. She has an academic background in preclinical MRI and PET Imaging, having completed her PhD and post-doctoral positions at the Danish Research Center for Magnetic Resonance (DRCMR) and Stanford University, School of Medicine’s Radiology Department.